Boehringer stroke drug proves a winner in trial
(Reuters)
Health / Medicine Related News
Reuters - Patients at risk of stroke due to an erratic heartbeat should soon have a viable alternative to 50-year-old warfarin, after a new pill from Boehringer Ingelheim beat expectations in a major clinical study.
Source: Yahoo! News: Medications/Drugs News